a claimed salt of alendronic acid in merck's patent (claim 23) is 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid monosodium salt trihydrate ("amt").
2 the importation of the drugs is scheduled for 31 october 2006.
this includes preventing the respondent from continuing to list or apply to list any one or more of those products for supply under the pharmaceutical benefits scheme.